Overview

Efficacy of Pilsicainide After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation

Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Investigators hypothesized that the use of Pilsicainide after radiofrequency ablation of AF could reduce the incidence of recurrence of atrial arrhythmia during follow up compared with other class IC antiarrhythmic drugs.
Phase:
N/A
Details
Lead Sponsor:
Korea University
Treatments:
Anti-Arrhythmia Agents
Flecainide
Lidocaine
Pilsicainide
Polystyrene sulfonic acid
Propafenone